Article
Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jan 2015
Fisher Randall G, Smith Davey M, Murrell Ben, Slabbert Ruhan, Kirby Bronwyn M, Edson Clair, Cotton Mark F, Haubrich Richard H, Kosakovsky Pond Sergei L, Van Zyl Gert U
Abstract excerpt
BACKGROUND: Next generation sequencing (NGS) allows the detection of minor variant HIV drug resistance mutations (DRMs). However data from new NGS platforms after Prevention-of-Mother-to-Child-Transmission (PMTCT) regimen failure are limited. OBJECTIVE: To compare major and minor variant HIV DRMs with Illumina MiSeq and Life Technologies Ion Personal Genome Machine (PGM) in infants infected despite a PMTCT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
